
Christina Jewett
Food and Drug Administration Reporter at The New York Times
New York Times investigative reporter covering the Food & Drug Administration. +boy mom, prodigal skier & nature lover // Tips? DM for Signal.
Articles
-
2 weeks ago |
mahoningmatters.com | Christina Jewett |Sheryl Gay Stolberg
WASHINGTON -- Three of the new advisers appointed by Health Secretary Robert F. Kennedy Jr. to guide the government on immunization policy took part in lawsuits casting doubt on the safety or efficacy of vaccines, public records show. In dismissing all 17 members of an influential Centers for Disease Control and Prevention advisory panel on Monday, Kennedy cited what he said was a history of conflicts of interest that he claimed made those experts a “rubber stamp” on approving vaccines.
-
2 weeks ago |
flipboard.com | Christina Jewett |Sheryl Gay Stolberg
Could the answers to cancer lie in space? Why off-Earth research is heating upAn experiment involving artificial organs is just one way researchers are trying to capitalize on the weird ways low-gravity environments affect the …
-
2 weeks ago |
estadao.com.br | Christina Jewett
A Food and Drug Administration (FDA, agência equivalente à Anvisa brasileira) está planejando usar inteligência artificial para “aumentar radicalmente a eficiência” na decisão de aprovar novos medicamentos e dispositivos, uma das várias prioridades estabelecidas em um artigo publicado na terça-feira, 10, no periódico JAMA.
-
2 weeks ago |
seattletimes.com | Christina Jewett
The Food and Drug Administration is planning to use artificial intelligence to “radically increase efficiency” in deciding whether to approve new drugs and devices, one of several top priorities laid out in an article published Tuesday in JAMA. Another initiative involves a review of chemicals and other “concerning ingredients” that appear in U.S. food but not in the food of other developed nations.
-
2 weeks ago |
nytimes.com | Christina Jewett
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market. The Food and Drug Administration is planning to use artificial intelligence to "radically increase efficiency" in deciding whether to approve new drugs and devices, one of several top priorities laid out in an article published Tuesday in JAMA.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 9K
- Tweets
- 7K
- DMs Open
- Yes

RT @ByJudyLin: “Really? After what just happened earlier this year in Los Angeles, we think fire safety and emergency preparedness is where…

RT @bencasselman: CBO is out with its final cost estimate of the tax-and-spending bill passed by the House. - Revenue ⬇️ by $3.7 trillion o…

RT @nytimes: Breaking News: The Trump administration has dealt a sharp blow to work on HIV vaccines, terminating a $258 million program cri…